References
- SumerBGaoJTheranostic nanomedicine for cancerNanomedicine (Lond)20083213714018373419
- FriasJCMaYWilliamsKJFayadZAFisherEAProperties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imagingNano Lett20066102220222417034087
- JacquesVDesreuxJNew Classes of MRI Contrast AgentsKrauseWContrast Agents I221Berlin/HeidelbergSpringer Verlag2002123
- FrullanoLRohovecJPetersJGeraldesCStructures of MRI Contrast Agents in SolutionKrauseWContrast Agents I221Berlin/HeidelbergSpringer Verlag200225
- TóthÉHelmLMerbachARelaxivity of MRI Contrast AgentsKrauseWContrast Agents I221Berlin/HeidelbergSpringer Verlag200261
- BrücherEKinetic Stabilities of Gadolinium(III) Chelates Used as MRI Contrast AgentsKrauseWContrast Agents I221Berlin/HeidelbergSpringer Verlag2002103
- KabalkaGWDavisMAMossTHGadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liverMagn Reson Med19911924064151881329
- SchnallMRosenMPrimer on imaging technologies for cancerJ Clin Oncol200624203225323316829646
- MulderWJStrijkersGJGriffioenAWA liposomal system for contrast-enhanced magnetic resonance imaging of molecular targetsBioconjug Chem200415479980615264867
- FrullanoLMeadeTJMultimodal MRI contrast agentsJ Biol Inorg Chem200712793994917659368
- KircherMFMahmoodUKingRSWeisslederRJosephsonLA multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineationCancer Res200363238122812514678964
- GianellaAJarzynaPAManiVMultifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancerACS Nano20115644224433
- KamalyNKalberTThanouMBellJDMillerADFolate receptor targeted bimodal liposomes for tumor magnetic resonance imagingBioconjug Chem200920464865519368341
- KamalyNKalberTAhmadABimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imagingBioconjug Chem200819111812917985841
- KluzaEvan der SchaftDWHautvastPASynergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesisNano Lett2010101525819968235
- van TilborgGAMulderWJChinPTAnnexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cellsBioconjug Chem200617486586816848390
- MulderWJStrijkersGJHabetsJWMR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticleFASEB J200519142008201016204353
- MulderWJvan der SchaftDWHautvastPAEarly in vivo assessment of angiostatic therapy efficacy by molecular MRIFASEB J200721237838317202248
- MulderWJKooleRBrandwijkRJQuantum dots with a paramagnetic coating as a bimodal molecular imaging probeNano Lett2006611616402777
- Van SchooneveldMMVucicEKooleRImproved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigationNano Lett2008882517252518624389
- SunCLeeJSZhangMMagnetic nanoparticles in MR imaging and drug deliveryAdv Drug Deliv Rev200860111252126518558452
- MulderWJStrijkersGJvan TilborgGAGriffioenAWNicolayKLipid-based nanoparticles for contrast-enhanced MRI and molecular imagingNMR Biomed200619114216416450332
- KamalyNMillerADParamagnetic liposome nanoparticles for cellular and tumour imagingInt J Mol Sci20101141759177620480040
- MulderWJStrijkersGJvan TilborgGACormodeDPFayadZANicolayKNanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imagingAcc Chem Res200942790491419435319
- KostarelosKMillerADSynthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectorsChem Soc Rev2005341197099416239997
- XiaWLowPSFolate-targeted therapies for cancerJ Med Chem201053196811682420666486
- SegaEILowPSTumor detection using folate receptor-targeted imaging agentsCancer Metastasis Rev200827465566418523731
- XiangGWuJLuYLiuZLeeRJSynthesis and evaluation of a novel ligand for folate-mediated targeting liposomesInt J Pharm20083561–2293618258394
- YooHSParkTGFolate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugateJ Control Release2004100224725615544872
- LeamonCPReddyJAFolate-targeted chemotherapyAdv Drug Deliv Rev20045681127114115094211
- AyyagariALZhangXGhaghadaKBAnnapragadaAHuXBellamkondaRVLong-circulating liposomal contrast agents for magnetic resonance imagingMagn Reson Med20065551023102916586449
- UngerENeedlemanPCullisPTilcockCGadolinium-DTPA liposomes as a potential MRI contrast agent Work in progressInvest Radiol198823129289323203995
- StrijkersGJMulderWJvan HeeswijkRBRelaxivity of liposomal paramagnetic MRI contrast agentsMAGMA200518418619216155762
- MaruyamaKPEG-liposome in DDS and clinical studiesNippon Rinsho19985636326379549348
- MullerCSchubigerPASchibliRIn vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99 mTc-radiofolate tracerEur J Nucl Med Mol Imaging200633101162117016721570